Share

Novavax CEO on delayed U.S. Covid-19 vaccine trial

Stanley Erck, president and CEO of Novavax, joins "Squawk Box" to discuss the trial delay in the U.S and why he thinks comparing Novavax's vaccine with a placebo vaccine is still the right comparative versus two other vaccines that have shown positive results.
02:08
Mon, Nov 30 20209:13 AM EST